Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Brian M, Murray"'
Publikováno v:
Medicine
Rationale: Lupus podocytopathy (LP) is an entity that is increasingly being reported in the literature on systemic lupus erythematosus (SLE). LP is characterized by nephrotic syndrome in SLE patients with diffuse glomerular podocyte foot process effa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::436c66a9ffe444b23cbb0ee0f9b4637c
http://europepmc.org/articles/PMC8448049
http://europepmc.org/articles/PMC8448049
Autor:
Neal Shah, Mandip Panesar, Winnie Su, Sarosh Vaqar, Mary Muscarella, Gregory D. Gudleski, Kaushik Ivaturi, Brian M. Murray, Judy Lambert
Publikováno v:
Therapeutic Apheresis and Dialysis. 21:157-165
Fresenius Medical Care's NaturaLyte dialysate has been associated with increased risk of sudden cardiac death by causing metabolic alkalosis from its acetate content based on retrospective data using pre-dialysis bicarbonate levels only. The study ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::505871d5a69310898709a4ede16dba94
https://doi.org/10.1111/1744-9987.12510
https://doi.org/10.1111/1744-9987.12510
Publikováno v:
American Journal of Clinical Pathology. 154:S68-S69
Introduction/Objective Lupus podocytopathy (LP), featured by nephrotic syndrome, is a unique subtype of lupus nephritis that mimics minimal change disease or primary focal segmental glomerulosclerosis (FSGS) on renal biopsy with diffuse podocyte foot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e449eff6a927ac15ebca1a79a7f44949
https://doi.org/10.1093/ajcp/aqaa161.149
https://doi.org/10.1093/ajcp/aqaa161.149
Autor:
Brian M. Murray
Publikováno v:
SSRN Electronic Journal.
While bipartisan passage of the First Step Act and state reforms like it will lead to changes in sentencing and release practices, they do little to combat the collateral consequences that ex-offenders face upon release. Because collateral consequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2253d25b97c3dafc55044c9bf0b2edf4
https://doi.org/10.2139/ssrn.3324807
https://doi.org/10.2139/ssrn.3324807
Autor:
Brian M. Murray, Mary Muscarella, Ryan Tulowitzki, Gregory D. Gudleski, Judy Lambert, Anne B. Curtis, Ryan E Krahn, Mandip Panesar, Winnie Su, Bharath Rajagopalan
Publikováno v:
American journal of nephrology. 49(1)
Background: The etiology of sudden cardiac death in patients with end-stage renal disease (ESRD) on hemodialysis (HD) is largely unknown, though there is evidence to suggest that metabolic alkalosis induced by HD with a high-bicarbonate dialysate/pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470b7d78cf56e96b2890e8ac7a539457
https://pubmed.ncbi.nlm.nih.gov/30602157
https://pubmed.ncbi.nlm.nih.gov/30602157
Autor:
Brian M. Murray
Publikováno v:
SSRN Electronic Journal.
This Article applies retributivist principles to discussions about collateral consequences reform. Retributivist ideas relating to agency and responsibility, proportionality, personal and communal restoration, and the obligations and duties of the st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::956380c860508c92705235cd06f04a18
https://doi.org/10.2139/ssrn.3426056
https://doi.org/10.2139/ssrn.3426056
Publikováno v:
Seminars in Dialysis. 27:472-476
The specialty of Nephrology, by virtue of its relationship with the dialysis procedure, is highly vulnerable to litigation. As is the case with all nephrologists, a dialysis unit medical director is not immune to medical malpractice suits, and can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b17d10c94471754bfac15f5e25b4a87d
https://doi.org/10.1111/sdi.12174
https://doi.org/10.1111/sdi.12174
Autor:
Rocco C. Venuto, J. James Bono, Laura Argauer, Pradeep Arora, Peter L. Elkin, Raghu Ram, Brian M. Murray, Joseph Eberle
Publikováno v:
BMC Nephrology
Background The database of a major regional health insurer was employed to identify the number and frequency of covered patients with chronic kidney disease (CKD). We then examined the characteristics of their care as defined, in part, by the frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c08d8d8fe91554d94caea3dd1766bc2
https://doi.org/10.1186/s12882-015-0194-2
https://doi.org/10.1186/s12882-015-0194-2
Autor:
Nauman Tahir, Neha Nainani, Rocco C. Venuto, Rakesh Kumar, Aijaz Gundroo, Kathleen M. Tornatore, Edit Weber-Shrikant, Nilang Patel, George A. Blessios, Brian M. Murray
Publikováno v:
Nephrology Dialysis Transplantation. 27:2077-2083
Background. The most common cause of late kidney transplant failure is insidiously progressive renal dysfunction associated with organ scarring and fibrosis. Advanced donor age, delayed graft function, calcineurin toxicity and repeated acute rejectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29fb2dd289726eaec1ba175709ad5f7b
https://doi.org/10.1093/ndt/gfr608
https://doi.org/10.1093/ndt/gfr608
Publikováno v:
The Journal of the American Board of Family Medicine. 21:522-530
Background: With the prevalence of chronic kidney disease (CKD) in the United States rising from 10% to 13%, implementation of the evidence-based Kidney Disease Outcomes Quality Initiative guidelines, which were developed for the delay of progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291a1697640a27acd2b4c483094380ea
https://doi.org/10.3122/jabfm.2008.06.080042
https://doi.org/10.3122/jabfm.2008.06.080042